Clinical Trial Details
| Trial ID: | L2546 |
| Source ID: | NCT01704612 |
| Associated Drug: | Ropivacaine |
| Title: | Evaluation of Block Duration in Type 2 Diabetes Patients |
| Acronym: | Diabeteblock |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Type 2 |
| Interventions: | DRUG: ropivacaine |
| Outcome Measures: | Primary: the duration of sensory block in hours, The beginning of this term is defined by the end of the sciatic block injection, and the end of this period is defined by the reappearance of sensitivity to pin-prick test, Day 0 | Secondary: the duration of motor sciatic block, The beginning of this term is defined by the end of the sciatic block injection, and the end of this period is defined by the reappearance of motor function, Day 0 | Other: Time necessary for onset sensory and motor block time in minutes, peroperative period, Day 0|Failure of the block: yes/no, perop, Day 0|occurrence of neurological omplications, yes/no, 1 month |
| Sponsor/Collaborators: | Sponsor: Pierre and Marie Curie University | Collaborators: Centre Hospitalier Universitaire de Nīmes |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 70 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT |
| Start Date: | 2011-07 |
| Completion Date: | 2012-03 |
| Results First Posted: | |
| Last Update Posted: | 2012-12-24 |
| Locations: | APHP Pitié-Sampetriere, Paris, 75013, France |
| URL: | https://clinicaltrials.gov/show/NCT01704612 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|